Journal Club 2016. 4. 29

Regulation of hepatic EAAT-2 glutamate transporter expression in human liver cholestasis.

AIM:

To investigate the activity and expression of EAAT2 glutamate transporter in both in vitro and in vivo models of cholestasis.

METHODS:

This study was conducted on human hepatoblastoma HepG2 cell cultures, the liver of bile duct ligated rats and human specimens from cholestatic patients. EAAT2 glutamate transporter activity and expression were analyzed using a substrate uptake assay, immunofluorescence, reverse transcription-polymerase chain reaction, and immunohistochemistry, respectively.

RESULTS:

In HepG2 cells, cholestasis was mimicked by treating cells with the protein kinase C activator, phorbol 12-myristate 13-acetate. Under such conditions, EAAT2 transporter activity was decreased both at the level of substrate affinity and maximal transport velocity. The decreased uptake was correlated with intracellular translocation of EAAT2 molecules as demonstrated using immunofluorescence. In the liver of bile duct ligated rats, an increase in EAAT2 transporter protein expression in hepatocytes was demonstrated using immunohistochemistry. The same findings were observed in human liver specimens of cholestasis in which high levels of γ-glutamyl transpeptidase were documented in patients with biliary atresia and progressive familial intrahepatic cholestasis type 3.

CONCLUSION:

This study demonstrates the alteration in glutamate handling by hepatocytes in liver cholestasis and suggests a potential cross-talk between glutamatergic and bile systems.

Regulation of hepatic EAAT-2 glutamate transporter expression in human liver cholestasis

Journal Club 2016. 4. 29 Read More »

Journal club 2016. 04. 22.

Long-Term Activation of Group I Metabotropic Glutamate Receptors Increases Functional TRPV1- Expressing Neurons in Mouse Dorsal Root Ganglia

Takayoshi Masuoka1*, Makiko Kudo1, Junko Yoshida1, Takaharu Ishibashi1,2, Ikunobu Muramatsu1, Nobuo Kato3, Noriko Imaizumi1 and Matomo Nishio1
1 Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Japan, 2 Department
of Pharmacology, School of Nursing, Kanazawa Medical University, Uchinada, Japan, 3 Department of Physiology I, School of Medicine, Kanazawa Medical University, Uchinada, Japan

fncel-10-00079

Damaged tissues release glutamate and other chemical mediators for several hours. These chemical mediators contribute to modulation of pruritus and pain. Herein, we investigated the effects of long-term activation of excitatory glutamate receptors on functional expression of transient receptor potential vaniloid type 1 (TRPV1) in dorsal root ganglion (DRG) neurons and then on thermal pain behavior. In order to detect the TRPV1-mediated responses in cultured DRG neurons, we monitored intracellular calcium responses to capsaicin, a TRPV1 agonist, with Fura-2. Long-term (4 h) treatment with glutamate receptor agonists (glutamate, quisqualate or DHPG) increased the proportion of neurons responding to capsaicin through activation of metabotropic glutamate receptor mGluR1, and only partially through the activation of mGluR5; engagement of these receptors was evident in neurons responding to allylisothiocyanate (AITC), a transient receptor potential ankyrin type 1 (TRPA1) agonist. Increase in the proportion was suppressed by phospholipase C (PLC), protein kinase C, mitogen/extracellular signal-regulated kinase, p38 mitogen-activated protein kinase or transcription inhibitors. Whole-cell recording was performed to record TRPV1-mediated membrane current; TRPV1 current density significantly increased in the AITC-sensitive neurons after the quisqualate treatment. To elucidate the physiological significance of this phenomenon, a hot plate test was performed. Intraplantar injection of quisqualate or DHPG induced heat hyperalgesia that lasted for 4 h post injection. This chronic hyperalgesia was attenuated by treatment with either mGluR1 or mGluR5 antagonists. These results suggest that long-term activation of mGluR1/5 by peripherally released glutamate may increase the number of neurons expressing functional TRPV1 in DRG, which may be strongly associated with chronic hyperalgesia.
Keywords: metabotropic glutamate receptors, TRPV1, TRPA1, dorsal root ganglion, heat hyperalgesia

Journal club 2016. 04. 22. Read More »

Journal Club 2016. 4. 15

Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2: Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2.

Abstract

Myeloid differentiation factor 2 (MD-2) is an extracellular protein, associated with the ectodomain of TLR4, that plays a critical role in the recognition of bacterial LPS. Despite high overall structural and functional similarity, human (h) and murine (m) MD-2 exhibit several species-related differences. hMD-2 is capable of binding LPS in the absence of TLR4, whereas mMD-2 supports LPS responsiveness only when mMD-2 and mTLR4 are coexpressed in the same cell. Previously, charged residues at the edge of the LPS binding pocket have been attributed to this difference. In this study, site-directed mutagenesis was used to explore the hydrophobic residues within the MD-2 binding pocket as the source of functional differences between hMD-2 and mMD-2. Whereas decreased hydrophobicity of residues 61 and 63 in the hMD-2 binding pocket retained the characteristics of wild-type hMD-2, a relatively minor change of valine to alanine at position 135 completely abolished the binding of LPS to the hMD-2 mutant. The mutant, however, retained the LPS binding in complex with TLR4 and also cell activation, resulting in a murine-like phenotype. These results were supported by the molecular dynamics simulation. We propose that the residue at position 135 of MD-2 governs the dynamics of the binding pocket and its ability to accommodate lipid A, which is allosterically affected by bound TLR4.

Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2; Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2

Journal Club 2016. 4. 15 Read More »

2016.04.08

Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling
Sabrina Cipriani1☯, Barbara Renga2☯, Claudio D’Amore2, Michele Simonetti2, Antonio
Angelo De Tursi2, Adriana Carino2, Maria Chiara Monti3, Valentina Sepe4,
Angela Zampella4, Stefano Fiorucci2*
1 Department of Medicine University of Perugia, Perugia, Italy, 2 Department of Surgery and Biomedical
Sciences, University of Perugia, Perugia, Italy, 3 Department of Pharmacy, University of Salerno, Salerno,
Italy, 4 Department of Pharmacy, University of Naples “Federico II”, Naples, Italy

Abstract
Background & Aims
In cholestatic syndromes, body accumulation of bile acids is thought to cause itching. However,
the mechanisms supporting this effect remain elusive. Recently, GPBAR1 (TGR5) a
G-protein coupled receptor has been shown to mediate itching caused by intradermal
administration of DCA and LCA. 6α-ethyl-3α, 7α-dihydroxy-24-nor-5β-cholan-23-ol
(BAR502) is a non-bile acid dual ligand for FXR and GPBAR1.
Methods
Cholestasis was induced in wild type and GPBAR1-/- mice by administration of α-naphthylisothiocyanate (ANIT) or 17α-ethynylestradiol.
Results.
In naïve mice skin application of DCA, TLCA, 6-ECDCA, oleanolic and betulinic acid
induces a GPBAR1 dependent pruritogenic response that could be desensitized by re-challengingthe mice with the same GPBAR1 agonist. In wild type and GPBAR1-/- mice cholestasisinduced by ANIT fails to induce spontaneous itching and abrogates scratching
behavior caused by intradermal administration of DCA. In this model, co-treatment with
BAR502 increases survival, attenuates serum alkaline phosphatase levels and robustly
modulates the liver expression of canonical FXR target genes including OSTα, BSEP, SHP
and MDR1, without inducing pruritus. Betulinic acid, a selective GPBAR1 ligand, failed to
rescue wild type and GPBAR1-/- mice from ANIT cholestasis but did not induced itching. In
the 17α-ethynylestradiol model BAR502 attenuates cholestasis and reshapes bile acid pool
without inducing itching.

Impaired itching perception in murine models of cholestasis is supported by dysregulation of GPBAR1 signalling

2016.04.08 Read More »

Journal club 2016-04-01

Transient receptor potential vanilloid 4 ion channel functions as a pruriceptor in epidermal keratinocytes to evoke histaminergic itch

+ Author Affiliations


  1. Duke University, United States

Abstract

TRPV4 ion channels function in epidermal keratinocytes and in innervating sensory neurons, however, the contribution of the channel in either cell to neurosensory function remains to be elucidated. We recently reported TRPV4 as a critical component of the keratinocyte machinery that responds to UVB, and functions critically to convert the keratinocyte into a pain-generator cell after excess UVB exposure. One key mechanism in keratinocytes was increased expression and secretion of endothelin-1, which is also a known pruritogen. Here we address the question whether TRPV4 in skin keratinocytes functions in itch, as a particular form of forefront signaling in non-neural cells. Our results support this novel concept, based on attenuated scratching behavior in response to histaminergic (histamine, compound 48/80, endothelin-1), not non-histaminergic (chloroquine) pruritogens in Trpv4 keratinocyte-specific and inducible knockout mice. We demonstrate that keratinocytes rely on TRPV4 for calcium influx in response to histaminergic pruritogens. TRPV4 activation in keratinocytes evokes phosphorylation of MAP-kinase, ERK, for histaminergic pruritogens. This finding is relevant because we observed robust anti-pruritic effects with topical applications of selective inhibitors for TRPV4 and also for MEK, the kinase upstream of ERK, suggesting that calcium influx via TRPV4 in keratinocytes leads to ERK-phosphorylation, which in-turn rapidly converts the keratinocyte into an organismal itch-generator cell. In support of this concept we found that scratching behavior, evoked by direct intradermal activation of TRPV4, was critically dependent on TRPV4-expression in keratinocytes. Thus, TRPV4 functions as a pruriceptor-TRP in skin keratinocytes in histaminergic itch, a novel basic concept with translational-medical relevance.

TRPV4 in histaminergic itch

Journal club 2016-04-01 Read More »

2016.03.18

Eact, a small molecule activator of TMEM16A, activates TRPV1 and elicits pain- and itch- related behaviours

Shenbin Liu1,2,*, Jing Feng1,*, Jialie Luo1, Pu Yang1, Thomas J Brett3 and Hongzhen Hu1

BACKGROUND AND PURPOSE

TMEM16A, also known as anoctamin 1 channel, is a member of the Ca2+-activated chloride channels family and serves as a heat sensor in the primary nociceptors. Eact is a recently discovered small molecule activator of the TMEM16A channel. Here, we asked if Eact produces pain- and itch-related responses in vivo and investigated the cellular and molecular basis of Eact-elicited responses in dorsal root ganglia (DRG) neurons.

EXPERIMENTAL APPROACH
We employed behavioural testing combined with pharmacological inhibition and genetic ablation approaches to identify transient receptor potential vanilloid 1 (TRPV1) as the prominent mediator for Eact-evoked itch- or pain-related responses. We investigated the effects of Eact on TRPV1 and TMEM16A channels expressed in HEK293T cells and in DRG neurons isolated from wild type and Trpv1/ mice using Ca2+ imaging and patch-clamp recordings. We also used site-directed mutagenesis to determine the molecular basis of Eact activation of TRPV1.

KEY RESULTS
Administration of Eact elicited both itch- and pain-related behaviours. Unexpectedly, the Eact-elicited behavioural responses were dependent on the function of TRPV1, as shown by pharmacological inhibition and genetic ablation studies. Eact activated membrane currents and increased intracellular free Ca2+ in both TRPV1-expressing HEK293T cells and isolated DRG neurons in a TRPV1-dependent manner. Eact activation of the TRPV1 channel was severely attenuated by mutations disrupting the capsaicin binding sites.

CONCLUSIONS AND IMPLICATIONS
Our results suggest that Eact activates primary sensory nociceptors and produces both pain and itch responses mainly through direct activation of TRPV1 channels.

 

Eact, a small molecule activator of TMEM16A, activates TRPV1 and elicits pain- and itch- related behaviours

2016.03.18 Read More »

Journal club 2016. 03. 04.

A Cell-Based Functional Assay Using a Green Fluorescent Protein-Based Calcium Indicator dCys-GCaMP
Bin Cai,1 Xia Chen,1 Fang Liu,1 Jun Li,1 Lijuan Gu,2 Jason R. Liu,3 and Jay Liu1
1Rugen Therapeutics Ltd., Suzhou Industrial Park, China. 2Biotech Development Co., Ltd., Suzhou Industrial Park, China. 3Summer Intern from Penn State University, University Park, Pennsylvania.

adt%2E2014%2E584

Measurement of the changes in intracellular Ca2+ levels is an important assay for drug discovery. In this report, we describe a novel Ca2+ indicator, dCys-GCaMP, based on the green fluorescent protein and the development of a rapid and simple cell-based functional assay using this new Ca2+ indicator. We demonstrated the sensitivity and reliability of the assay by measuring the cellular responses to the agonists, antagonists, channel blockers, and modulators of the ionotropic N-methyl-D-aspartate (NMDA) subtype of glutamate receptors. HEK293 cells coexpressing the NMDA receptor and dCys-GCaMP displayed a strong increase in fluorescence intensity when stimulated with the agonist glutamate. This increase in the fluorescence signal was agonist concentration dependent and could be blocked by NMDAR antagonists and channel blockers. The pharmacological parameters measured with the dCys-GCaMP assay are in close agreement with those derived from conventional assays with synthetic dye fluo-4 and literature values. In addition, we showed that this assay could be used on G protein-coupled receptors as well, as exemplified by studies on the a1A adrenergic receptor. A limited scale evaluation of the assay performance in a 96-well compound screening format suggests that the dCys-GCaMP assay could be easily adapted to a high-throughput screening environ- ment. The most important advantage of this new assay over the con- ventional fluo-4 and aequorin assays is the elimination of the dye-loading or substrate-loading process.

Journal club 2016. 03. 04. Read More »

Journal club 2016. 03. 11.

Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists
Kerstin Hill,*,† Serena Fiorito,‡ Vito Alessandro Taddeo,‡ Anja Schulze,§ Marion Leonhardt,† Francesco Epifano,*,‡ and Salvatore Genovese‡
†Rudolf-Boehm-InstitutfürPharmakologieundToxikologie,UniversitaẗLeipzig,Har̈telstr.16-18,04107Leipzig,Germany ‡Department of Pharmacy, University “G. D’Annunzio” of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy §Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Biozentrum, Weinbergweg 22, 06120 Halle, Germany

Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists

ABSTRACT: A series of seven oxyprenylated phenylpropanoids and naphthoquinones were tested regarding their ability to activate transient receptor potential ankyrin subtype 1 channel (TRPA1). Three of the assayed compounds, namely, boropinal (3), juglone (5), and plumbagin (7), acted as strong modulators of TRPA1 channels with EC50 values of 9.8, 1.7,and 0.5 μM, respectively, as assessed by Ca2+ assays. Moreover, the compounds elicited TRPA1 currents in electrophysiological whole cell recordings. We additionally provide evidence that plumbagin activated TRPA1-positive neurons isolated from mouse dorsal root ganglion neurons but did not affect sensory neurons from TRPA1-deficient mice. The high potencies of plumbagin and juglone to activate TRPA1 channels may explain the molecular basis of the mucosal irritant properties of these compounds as well as of related naphthoquinones and phytopreparations, as widely reported in the literature.

Journal club 2016. 03. 11. Read More »

Journal club 2016. 2. 26

PPARγ ameliorated LPS induced inflammation of HEK cell line expressing both human Toll-like receptor 4 (TLR4) and MD2.

1Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Velenjak, 1985717443, Tehran, Iran.

Abstract

TLR4 is transmembrane pattern-recognition receptor that initiates signals in response to diverse pathogen-associated molecular patterns especially LPS. Recently, there have been an increasing number of studies about the role of TLRs in the pathogenesis of several disorders as well as the therapeutic potential of TLR intervention in such diseases. Peroxisome proliferator-activated receptor-gamma (PPARγ) is a ligand-activated transcription factor with numerous biological effects. PPARγ has been shown to exert a potential anti-inflammatory effect through suppression of TLR4-mediated inflammation. Therefore, PPARγ agonists may have a potential to combat inflammatory conditions in pathologic states. The current study aims to show the decrease of inflammation by overexpression of PPARγ in a cell reporter model. To reach this goal, recombinant pBudCE4.1 (+) containing encoding sequences of human TLR4 and MD2 was constructed and used to transfect HEK cells. Subsequently, inflammation was induced by LPS treatment as control group. In the treatment group, overexpression of PPARγ prior to inflammation was performed and the expression of inflammatory markers was assessed in this condition. The expression of inflammatory markers (TNFα and iNOS) was defined by quantitative real time PCR and the amount of phosphorylated NF-κB was measured by western blot. Data indicated expression of TNFα and iNOS increased in LPS induced inflammation of stably transformed HEK cells with MD2 and TLR4. In this cell reporter model overexpression of PPARγ dramatically prevented LPS-induced inflammation through the blocking of TLR4/NF-κB signaling. PPARγ was shown to negatively regulate TLR4 activity and therefore exerts its anti-inflammatory action against LPS induced inflammation.

PPARγ ameliorated LPS induced inflammation of HEK cell line expressing both human Toll-like receptor 4 (TLR4) and MD2

Journal club 2016. 2. 26 Read More »

Journal club 2016-02-19

Voltage-Gated Potassium Channels Involved in Regulation of Physiological Function in MrgprA3-Specific Itch Neurons.

Abstract

Itch is described as an unpleasant or irritating skin sensation that elicits the desire or reflex to scratch. MrgprA3, one of members of the Mrgprs family, is specifically expressed in a subpopulation of dorsal root ganglion (DRG) in the peripheral nervous system (PNS). These MrgprA3-expressing DRG neurons have been identified as itch-specific neurons. They can be activated by the compound, chloroquine, which is used as a drug to treat malaria. In the present study, we labeled these itch-specific neurons using the method of molecular genetic markers, and then studied their electrophysiological properties. We also recorded the cutaneous MrgprA3 neurons retrogradely labeled by Dil dye (MrgprA3-Dil). We first found that MrgprA3+ neurons have a lower excitability than MrgprA3 neurons (MrgprA3-non-Dil and MrgprA3-Dil). The number of action potential (AP) was reduced more obviously in MrgprA3+ neurons than that of in MrgprA3 neurons. In most cases, MrgprA3+ neurons only generated single AP; however, in MrgprA3 neurons, the same stimulation could induce multiple AP firing due to the greater voltage-gated potassium (Kv) current existence in MrgprA3+ than in MrgprA3 neurons. Thus, Kv current plays an important role in the regulation of excitability in itch-specific neurons.

Copyright © 2016. Published by Elsevier B.V.

KEYWORDS:

DRG; Itch; Kv current; MrgprA3

 

voltage gated K+ channel and Mrgpra3 specific itchneuron

Journal club 2016-02-19 Read More »

Scroll to Top